# Actavis Pharma Development Centre Private Ltd – FDA Inspection, Jul 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/actavis-pharma-development-centre-private-ltd/f4b50a47-352d-4c79-a450-f322b88b6b1a
Source feed: FDA_Inspections

> FDA inspection 1210944 of Actavis Pharma Development Centre Private Ltd, July 11, 2023. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210944
- Company Name: Actavis Pharma Development Centre Private Ltd
- Inspection Date: 2023-07-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1025933 - 2017-09-21](https://www.keypedia.com/records/fda_inspections/actavis-pharma-development-centre-private-ltd/595f0374-7fa3-45f6-a1a0-a7809eb3c64d)
- FDA Inspection 909974 - 2014-12-05
- FDA Inspection 752923 - 2011-10-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)

Company: https://www.keypedia.com/companies/actavis-pharma-development-centre-private-ltd/4feafce4-9d07-4208-b3d4-23a4cfaada15

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c